11th Central European Lung Cancer Conference > June 12-14, 2008, Ljubljana, Slovenia
Detailed Programme
Thursday, June 12
| 10.00-19.00 | Registration |
|||
| 13.00-13.30 | CELCC Welcome Address |
|||
| 13.30-15.40 | Session I: PREVENTION, EARLY DETECTION AND DIAGNOSIS Chairs: Pieter Postmus, Nadja Triller |
|||
| 13.30 | LUNG CANCER IN SLOVENIA, REGISTRY REPORT Maja Primic Žakelj |
|||
| 13.50 | LUNG CANCER IN NEVER SMOKERS Gyula Ostoros |
|||
| 14.10 | EARLY DIAGNOSIS OF LUNG CANCER Marjeta Terčelj |
|||
| 14.30 | CURRENT ROLE OF COMPUTER ASSISTED DEVICE SYSTEMS FOR PULMONARY NODULES Catherine Beigelman |
|||
| 14.50 | THE ROLE OF NARROW-BAND IMAGING (NBI) VIDEOBRONCHOSCOPY IN THE ASSESSMENT OF TUMOR EXTENSION IN LUNG CANCER Bojan Zarić |
O-1 | ||
| 15.00 | THE FEASIBILITY OF COMPUTER ASSISTED ANALYSIS OF INDUCED SPUTUM SAMPLES FOR LUNG CANCER DIAGNOSIS. Maya Gottfried |
O-2 | ||
| 15.10 | THE IMPORTANCE OF CHROMOGRANIN –A IN LUNG CANCER PATIENTS Lubos Holubec |
O-3 | ||
| 15.20 | THE ROLE OF MONOTOTAL IN RELATION TO OTHER CYTOKERATINS IN THE PRIMARY DIAGNOSIS AND FOLLOW-UP OF PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC) Ondrej Topolcan |
O-4 | ||
| 15.30 | BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA ANGIOTENSIN-CONVERTING ENZYME ACTIVITY AS A PROGNOSTIC TUMOR MARKER IN PATIENTS WITH BRONCHIAL CARCINOMA Tevfik Kaplan |
O-5 | ||
| 15.40-16.10 | Coffee break |
|||
| 15.40-16.10 | POSTER VIEWING Poster chairs: Mircea Dediu, Matjaž Turel |
|||
| MDM2 309T/G POLYMORPHISM AND THE RISK OF NON SMALL CELL LUNG CANCER (NSCLC) DEVELOPMENT Adrianna Drozdowska |
P-1 | |||
| MARKERS OF PROLIFERATION ACTIVITY IN NON-SMALL CELL LUNG CANCER Irena Vasutova |
P-2 | |||
| EXPRESSION PROFILES OF THE RADIORESISTANCE RELATED GENES IN A NSCLC CELL LINE, H460. Moon-June Cho |
P-3 | |||
| PROMOTER METHYLATION OF CDKN2A, RARB, RASSF1A IN NON SMALL CELL LUNG CANCER: QUANTITATIVE EVALUATION USING PYROSEQUENCING METHOD Meehye Kwon |
P-4 | |||
| NOVEL BIOMARKERS IN EARLY STAGES OF LUNG ADENOCARCINOMA IDENTIFIED WITH OLIGONUCLEOTIDE BASED DNA MICROARRAYS Vid Mlakar |
P-5 | |||
| LIPOPROTEIN LIPASE ACTIVITY AND GENE EXPRESSION IN LUNG CANCER AND IN ADJACENT NON-CANCER LUNG TISSUE Zoran Trošt |
P-6 | |||
| MICRO RNAS IN LUNG CANCER Maya Gottfried |
P-7 | |||
| RELATIONSHIP BETWEEN VEGF WITH RADIOTHERAPY FOR LUNG CANCER Orhan Kizilkaya |
P-8 | |||
| 16.10-17.50 | Session II: BIOLOGY, PATHOLOGY AND STAGING Chairs: Martin Filipits, Izidor Kern |
|||
| 16.10 | MOLECULAR PATHOGENESIS OF LUNG CANCER Tomaž Rott |
|||
| 16.30 | MOLECULAR PROGNOSTIC AND PREDICTIVE FACTORS Bruno Murer |
|||
| 16.50 | NEW STAGING SYSTEM OF LUNG CANCER Pieter Postmus |
|||
| 17.10 | PREOPERATIVE LYMPH NODE STAGING Paul De Leyn |
|||
| 17.30 | ENDOBRONCHIAL ULTRASOUND IN THE DIAGNOSIS OF PERIPHERAL PULMONARY LESIONS Nadja Triller |
|||
| 18.00 | OPENING CEREMONY & WELCOME RECEPTION |
Friday, June 13
| 7.00-19.00 | Registration |
|||
| 8.00- 9.40 | Session III: ADVANCED NSCLC Chairs: Petr Zatloukal, Uroš Smrdel |
|||
| 8.00 | FIRST-LINE CHEMOTHERAPY IN ADVANCED NSCLC THERAPY Matjaž Zwitter |
|||
| 8.20 | MANAGEMENT OF PATIENTS WITH NSCLC IN PROGRESSION AFTER 1ST LINE CHEMOTHERAPY Mircea Dediu |
|||
| 8.40 | PREDICTIVE FACTORS FOR CHEMOTHERAPY Martin Filipits |
|||
| 9.00 | TREATMENT OF LUNG CANCER IN DEVELOPING COUNTRIES Purvish M. Parikh |
|||
| 9.20 | THE PREDICTIVE VALUE OF TOTAL VS. AMPLIFICABLE FREE-CIRCULATING DNA IN PLASMA OF NSCLC PATIENTS – A PRELIMINARY STUDY Adam Szpechcinski |
O-6 | ||
| 9.30 | FEMALE SEX AS PROGNOSTIC FACTOR IN LUNG CANCER: EFFECTS OF THE EXPRESSION OF ESTROGEN NUCLEAR RECEPTORS IN LUNG CANCER Nensi Lalic |
O-7 | ||
| 9.40-10.10 |  Satellite Symposium sponsored by Eli Lilly:PROGRESSES IN THE MANAGEMENT OF ADVANCED NSCLC Chair: Matjaž Zwitter, Ljubljana, Slovenia |
|||
| OPTIMIZING PATIENT BENEFIT IN THE 1ST LINE TREATMENT OF ADVANCED NSCLC: FROM PAST TO FUTURE Johan Vansteenkiste, Leuven, Belgium |
||||
| BEYOND FIRST LINE THERAPY: WHICH TREATMENT OPTIONS TO CONSIDER IN OVERALL TREATMENT STRATEGY? Nicolas Thatcher, Manchester, UK |
||||
| 10.10-10.40 |
 sponsored by Johnson & Johnson |
|||
| 10.10-10.40 | POSTER VIEWING Poster chairs: Joseph Timar, Marko Bitenc |
|||
| SOME CHARACTERISTICS OF METASTATIC PATTERN IN STAGE IV LUNG CANCER Aleksandar Tepavac |
P-9 | |||
| SYSTEMIC SCLEROSIS AND LUNG CANCER: A CASE REPORT Danica Sazdanić-Velikić |
P-10 | |||
| PARTIAL RESPONSE FOLLOWING PEMETREXED THERAPY IN HEAVY PRETREATED PATIENT WITH LUNG ADENOCARCINOMA EIGHT YEARS AFTER DISEASE DISSEMINATION TO THE LUNG Maria Cerna |
P-11 | |||
| SINGLE AGENT PEMETREXED IN POOR PERFORMANCE STATUS PATIENTS WITH RECURRENT, ADVANCED NON-SMALL CELL LUNG CANCER Sun Young Kim |
P-12 | |||
| COMPLETE REMISSION IN A PATIENT TREATED WITH 2º LINE CHEMOTHERAPY WITH VINFLUNINE – CASE REPORT Direndra Hasmucrai |
P-13 | |||
| RANDOMIZED PHASE IIB TRIAL EVALUATING THE THERAPEUTIC VACCINE TG4010 (MVA-MUC1-IL2) AS AN ADJUNCT TO CHEMOTHERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). Zsolt Papai |
P-14 | |||
| SURGICAL TREATMENT RESULTS IN STAGE I NSCLC PATIENTS Daliborka Bursac |
P-15 | |||
| HSP70 EXPRESSION PREDICTS BETTER OUTCOMES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AFTER OPERATION AND ADJUVANT CHEMOTHERAPY Jae Cheol Lee |
P-16 | |||
| BONE MARROW DERIVED STEM CELLS (BMSC) AFTER LUNG RESECTIONS Matevz Srpčič |
P-17 | |||
| 10.40-12.10 | Session IV: TARGETED THERAPY Chairs: Nick Thatcher, Brane Zakotnik |
|||
| 10.40 | EGFR DIRECTED THERAPY Robert Pirker |
|||
| 11.00 | DUAL AND MULTIKINASE INHIBITORS Joseph Timar |
|||
| 11.20 | OTHER TARGETS Rolf Stahel |
|||
| 11.40 | HIGHLIGHTS FROM ASCO 2008 - PET CT Johan Vansteenkiste |
|||
| 12.00 | CAN TUMOR MARKERS IMPROVE THE DIAGNOSTIC ACCURACY OF DIFFERENTIAL DIAGNOSTICS OF PLEURAL EFFUSIONS? David Havel |
O-8 | ||
| 12.10 -12.40 |  Satellite Symposium sponsored by RocheCLINICAL EXPERIENCE WITH AVASTIN IN NSCLC Viljem Kovač (chairman); Nicolas Thatcher, Olga Cerar, Martina Vrankar |
|||
| 12.40-13.40 | Lunch | |||
| 13.40-15.30 | Session V: EARLY NSCLC Chairs: Johan Vansteenkiste, Anton Crnjac |
|||
| 13.40 | AUTOFLUORESCENCE BRONCHOSCOPY Andrej Debeljak |
|||
| 14.00 | LIMITED RESECTION: A REAPPRAISAL Miha Sok |
|||
| 14.20 | SYSTEMIC THERAPY Robert Pirker |
|||
| 14.40 | THE ROLE OF RADIOTHERAPY IN EARLY NSLCC Antonio Juretić |
|||
| 15.00 | TECHNIQUE AND VALUE OF THE SENTINEL NODE DETECTION DURING THE LUNG RESECTION FOR THE EARLY STAGE NSCLC Vaclav Jedlicka |
O-09 | ||
| 15.10 | BRONCHIAL CARCINOID TUMORS: SURGICAL MANAGEMENT AND LONG-TERM OUTCOME Fadil Gradica |
O-10 | ||
| 15.20 | ROLE OF INTRAOPERATIVE ULTRASOUND FOR MEDIASTINAL STAGING IN NON-SMALL CELL LUNG CANCER SURGERY Nenad Ilic |
O-11 | ||
| 15.30-16.00 |  Coffee breakSponsored by Pfizer |
|||
| 15.30-16.00 | POSTER VIEWING Poster chairs: Radoslav Jaković, Jože Jerman |
|||
| OUR EXPERIENCE IN THE TREATMENT AND OVERALL SURVIVAL OF SMALL CELL LUNG CANCER PATIENTS TREATED AT THE ONCOLOGY DEPARTMENT OF SINGLETON HOSPITAL, SWANSEA, UK: DR ANUPAM CHAUDHURI, DR KATHRYN ROWLEY Anupam Chaudhuri |
P-18 | |||
| SURVIVAL OF PATIENTS WITH SMALL-CELL LUNG CANCER Nevena Secen |
P-19 | |||
| MULTIPLE PRIMARY MALIGNANT NEOPLASMS IN PATIENTS WITH SMALL CELL LUNG CANCER Nektarios Alevizopoulos |
P-20 | |||
| MALIGNANT MESOTHELIOMA IN UNIVERSITY LUNG CLINIC SARAJEVO BETWEEN 1998-2007 Aida Ustamujic |
P-21 | |||
| FAMILIAL MESOTHELIOMA OF THE PLEURA. A REPORT OF 8 CASES Claudio Bianchi |
P-22 | |||
| THE INCIDENCE OF SERIOUS VENOUS THROMBOEMBOLIC EVENTS IN LUNG CANCER PATIENTS Bohdan Kadlec |
P-23 | |||
| PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBE FEEDING IN PATIENTS WITH LUNG CANCER Miroslav Vujasinović |
P-24 | |||
| PHARMACOKINETIC STUDY OF TRANSDERMAL FENTANYL PATCH IN PATIENTS WITH CANCER PAIN V. Nisevic |
P-25 | |||
| MANAGEMENT OF PAIN IN PATIENTS WITH LUNG CANCER USING VISUAL ANALOGUE SCALE Jožica Jošt |
P-26 | |||
| INFORMING OF PATIENTS WITH LUNG CANCER WHO ARE TREATED WITH CHEMOTHERAPY AND THEIR FAMILIES Nataša Žižmond |
P-27 | |||
| LUNG AND PLEURAL METASTASES OF A BREAST CANCER TREATED IN CLINIC FOR PULMONARY DISEASES AND TB « PODHRASTOVI» IN THE FOUR-YEAR PERIOD FROM 2003–2006 Vesna Cukic |
P-28 | |||
|
DEVELOPMENT OF PALLIATIVE CARE AT THE UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES GOLNIK |
P-29 | |||
| FAMILY ORIENTED COMMUNICATION IN PALLIATIVE CARE Urška Lunder |
P-30 | |||
| 16.00-17.50 | Session VI: NSCLC STAGE III Chairs: Lubos Petruželka, Vili Kovač |
|||
| 16.00 | CHEMORADIOTHERAPY Petr Zatloukal |
|||
| 16.20 | ROLE OF SURGERY Stanko Vidmar |
|||
| 16.40 | HIGHLIGHTS FROM ASCO 2008. TREATMENT OF NSCLC STAGE III Lubos Petruzelka |
|||
| 17.00 | CONCENTRATIONS OF ANGIOGENIN AND VEGF IN PATIENTS WITH LUNG CANCER Aleš Rozman |
O-12 | ||
| 17.10 | PAI-1 NEGATIVELY CONTROLS THE LUNG CANCER CELLS PROLIFERATION Adam Szpechcinski |
O-13 | ||
| 17.20 | GENE EXPRESSION SIGNATURE IN WOMAN WITH NON-SMALL CELL LUNG CANCER (NSCLC) ACCORDING TO CIGARETTE SMOKING Amelia Szymanowska |
O-14 | ||
| 17.30 | A PROGNOSTIC 3-GENE EXPRESSION PROFILE (RT-PCR) IN EARLY-STAGE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS Marcin Skrzypski |
O-15 | ||
| 17.40 | DAILY CARBOPLATIN AND THORACIC RADIOTHERAPY IN ELDERLY PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER Peter Berzinec |
O-16 | ||
| 17.50 -18.20 |  Satellite Symposium sponsored by GlaxoSmithKline:CURRENT TREATMENT STANDARDS FOR SCLC - IMPORTANCE AND RELEVANCE OF HYCAMTIN Viljem Kovač (chairman); Robert Pirker |
|||
| 20.00 | SLOVENIAN EVENING |
Saturday, June 14
| 8.00-14.00 | Registration |
|||
| 9.00-10.10 | Session VII: MANAGEMENT OF MESOTHELIOMA & Session VIII: TREATMENT OF SCLC Chairs: Antonio Juretič, Matjaž Zwitter |
|||
| 9.00 | SYSTEMIC TREATMENT OF MESOTHELIOMA Vili Kovač |
|||
| 9.20 | SURGERY OF PLEURAL MESOTHELIOMA Radoslav Jaković |
|||
| 9.40 | THERAPY OF SCLC Pieter Postmus |
|||
| 10.00 | MALIGNANT MESOTHELIOMA OF THE PLEURA IN THE TRIESTE-MONFALCONE DISTRICT, ITALY. A 40-YEAR STUDY IN AN AREA AT HIGH RISK Claudio Bianchi |
O-17 | ||
| 10.10 | EVALUATION OF RIGID THORACOSCOPY IN THE DIAGNOSIS OF SUSPECTED PLEURAL TUMOURS: ACCURACY, SAFETY AND OUTCOME Aleš Rozman |
O-18 | ||
| 10.20-11.40 | PRESIDENTIAL SYMPOSIUM Chairs: Miha Sok, Andrej Debeljak |
|||
| 10.20 | HONORARY LECTURE: PAST AND FUTURE OF CELCC Jean Klastersky |
|||
| 10.40 | ANTITOBACCO REGULATIONS IN EUROPE Vesna Kerstin Petrič |
|||
| 11.00 | HIGHLIGHTS FROM 1ST ELCC: IS THERE ANY PROGRES IN ROUTINE MANAGEMENT OF LUNG CANCER? Lučka Debevec |
|||
| 11.20 | Nomination of best posters (3), best papers (3) | |||
| 11.40-12.10 | Coffee break | |||
| 12.10 -13.30 | Session IX: MANAGEMENT OF TUMOR AND TREATMENT RELATED SYMPTOMS Chairs: Gyula Ostoros, Marjeta Terčelj |
|||
| 12.10 | MANAGEMENT OF THE SIDE EFFECTS OF TARGETED THERAPIES Jean Klastersky |
|||
| 12.30 | ANEMIA Robert Pirker |
|||
| 12.50 | INTERVENTIONAL BRONCHOSCOPY IN PATIENTS WITH CENTRAL AIRWAY OBSTRUCTION BECAUSE OF UNRESECTABLE LUNG CANCER Nadja Triller |
|||
| 13.10 | NUTRITIONAL SUPPORT IN LUNG CANCER TREATMENT Nada Rotovnik Kozjek |
|||
| 13.30 | Closing |